Home > Healthcare > Medical Devices > Implantable Devices > Spinal Fusion Device Market
Spinal Fusion Device Market size was valued at over USD 8.35 billion in 2023 and is expected to register 4.6% CAGR from 2024 to 2032 due to the increasing prevalence of spinal disorders, such as degenerative disc disease, spondylolisthesis, and spinal stenosis. As these conditions become more common, the demand for effective treatments including spinal fusion devices is rising.
Healthcare providers are increasingly adopting these devices to address the growing number of patients with spinal issues. This factor is expected to continue as advancements in medical technology are improving the efficacy and safety of spinal fusion procedures. Moreover, the market will witness expansion with the ongoing need to manage and treat spinal disorders effectively. For instance, in April 2024, WHO reported that over 15 million people globally live with spinal cord injury (SCI). This rising prevalence is underscoring the need for spinal fusion devices which are crucial for effective treatment, rehabilitation, and improving the quality of life for SCI patients.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Spinal Fusion Device Market Size in 2023: | USD 8.35 Billion |
Forecast Period: | 2024 - 2032 |
Forecast Period 2024 - 2032 CAGR: | 4.6% |
2032 Value Projection: | USD 12.9 Billion |
Historical Data for: | 2018 - 2023 |
No. of Pages: | 230 |
Tables, Charts & Figures: | 406 |
Segments covered: | Product Type, Disease Type, Surgery, Material Type, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The market is experiencing growth due to continuous technological advancements. Innovations, such as minimally invasive surgical techniques, biologics, and advanced materials like titanium and carbon fiber are enhancing surgical outcomes. These advancements are making spinal fusion procedures safer, more effective, and less invasive, thus attracting more healthcare providers and patients.
In the future, the integration of cutting-edge materials and techniques will continue driving the product demand for ensuring better patient outcomes and expanding the adoption of spinal fusion devices globally. For instance, in November 2023, Orthofix Medical Inc. announced the full U.S. commercial launch of the WaveForm® L Lateral Lumbar Interbody System. This 3D-printed spinal fusion device is designed for LLIF procedures and features a porous structure to enhance strength and stability while promoting a robust fusion environment.
On the other hand, the higher cost of surgery and devices may deter the product adoption to some degree. Patients are increasingly considering alternative treatments that are more affordable and less invasive. This factor is expected to persist and potentially limit the market growth as cost-effective and non-surgical options are gaining popularity.
The spinal fusion device industry is benefiting from the increasing partnerships and collaborations among medical device companies, research institutions, and healthcare providers. These strategic alliances are facilitating the sharing of knowledge, resources, and technology, leading to innovative product developments, and enhanced surgical techniques. The ongoing cooperative efforts are also crucial for addressing the growing demand for effective spinal fusion solutions globally.
For instance, in June 2023, GE HealthCare partnered with J&J to advance the OEC 3D spine imaging system. This mobile system captures 2D and 3D images during operations and provides images while displaying more levels during spinal fusion to enhance procedural accuracy and outcomes.
Furthermore, patients and healthcare providers are preferring minimally invasive surgery (MIS) procedures due to their benefits, including reduced recovery time and lower risk of complications. The rapid advancements in MIS technologies are boosting the product popularity and utilization in spinal fusion surgeries.
Based on product type, the thoracolumbar devices segment is projected to exceed USD 6.8 billion by 2032. This surge is due to the increasing prevalence of spinal disorders and the growing demand for surgical interventions targeting the thoracic and lumbar regions. As healthcare is continuing to prioritize innovative solutions, there have been advancements in surgical techniques and technologies. The ongoing R&D initiatives aimed at enhancing the effectiveness and safety of thoracolumbar devices will further propel their prominence.
Based on disease type, the spinal fusion device market from the degenerative disc segment held significant revenue share in 2023 and will be valued at over USD 6 billion by 2032, due to the rising prevalence of smoking, poor nutrition, and lack of regular exercise. With the aging global population, there is an increasing number of people at risk of developing degenerative disc. The improved awareness of the disease among both patients and healthcare providers, along with advancements in diagnostic imaging technology, has led to its earlier detection and diagnosis, adding to the product demand.
Based on surgery, the spinal fusion device market size from the minimally invasive spine surgery segment is set to reach over USD 8.4 billion by 2032. Minimally invasive techniques make use of smaller incisions and specialized instruments, resulting in less disruption to surrounding tissues, muscles, and nerves compared to traditional open surgery. Moreover, reduced tissue trauma leads to less postoperative pain, faster recovery times, and shorter hospital stays, driving the patient demand for minimally invasive approaches.
Based on material type, the metallic devices segment will witness 4.5% CAGR from 2024 to 2032, as they offer strength and stability, particularly in cases, such as complex spinal deformity corrections. Innovations in spinal fusion devices, including the development of minimally invasive surgical techniques are making procedures safer, and effective with faster recovery times. Metallic spinal fusion devices render high strength and durability as they are made from materials like titanium or stainless steel. These devices also provide excellent stabilization of the spine, which is crucial for the proper healing and fusion of the vertebrae.
In terms of application, the hospitals segment of the spinal fusion device market is expected to surpass USD 7.1 billion by 2032. This expansion is due to the increasing demand for spinal fusion procedures in hospital settings, driven by rising cases of spinal disorders and advancements in surgical techniques. Additionally, hospitals are continuing to invest in state-of-the-art equipment and facilities to enhance patient care and surgical outcomes. As healthcare systems are evolving and focusing on providing comprehensive spinal care, hospitals are garnering high preference. Continued advancements in surgical technologies and increasing patient access to specialized spinal care within hospital settings will favor segment.
North America spinal fusion device market is predicted to record over USD 6.7 billion by 2032. The increase in sports-related injuries is contributing to the rising demand for spinal fusion procedures and devices. As sports activities continue to be popular and accessible, the incidence of such injuries is remaining constant. Additionally, the expansion of healthcare facilities and services across the region are ensuring greater accessibility to spinal fusion treatments. The surging rate of sports participation and improvements in healthcare infrastructure will further favor the regional industry growth.
Leading players in the spinal fusion device industry are coming up with product launches and collaborating through partnerships, mergers, and acquisitions to enhance their competitiveness. They are also developing new technologies and strategies to maintain their global position.
Click here to Buy Section of this Report
Market, By Product Type
Market, By Disease Type
Market, By Surgery
Market, By Material Type
Market, By End-use
The above information is provided for the following regions and countries: